Salicylic Acid 0.5%
Over-the-CounterHandelsnamen: Lacura Blemish Dots Conceal and Treat
About This Medication
Topical topical formulated to treat acne breakouts, reduce blemishes, and help prevent new pimples.
Wirkstoffe
| Wirkstoff | Stärke |
|---|---|
| Salicylic Acid | - |
Indikationen und Anwendung
Dosierung und Verabreichung
Warnhinweise und Vorsichtsmaßnahmen
Warnings For external use only. When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Frequently Asked Questions
Uses soothe and helps diminish the redness and irritation of blemished skin and a sorbs excess oil for faster healing.
Directions Cleanse and dry facem, removing and makeup. Apply one healing dot, sticky side down, over your blemish. Leave the healing dot over blemish for at least 6 hours or overnight Repeat as necessary with a new healing dot.
Warnings For external use only. When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Salicylic Acid 0.5% is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Salicylic Acid 0.5% drug label (National Library of Medicine)
- • openFDA — Salicylic Acid 0.5% label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 1994404 (NLM Normalized Drug Names)
- • NDC Directory — Salicylic Acid 0.5% (FDA National Drug Code)
Medizinischer Haftungsausschluss
Die Informationen auf dieser Seite dienen ausschließlich zu Bildungszwecken und sollten nicht als Ersatz für professionellen ärztlichen Rat, Diagnose oder Behandlung verwendet werden.
Wenden Sie sich bei Fragen zu einem medizinischen Zustand oder einem Arzneimittel stets an Ihren Arzt oder einen anderen qualifizierten Angehörigen der Gesundheitsberufe.
Datenquellen: DailyMed (NLM), openFDA, MFDS